Global ICD & CRT-D Market Reviewed in New Analytical Report Recently Published by MarketPublishers.com

Share Article

The global implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy-defibrillators (CRT-D) market is forecast to grow at a CAGR of 5% over the period 2010-2017 to reach revenue of USD 9.8 billion by 2017. New research report “Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” developed by GlobalData has been recently published by Market Publishers Ltd.

marketpublishers.com

Market Publishers Ltd

The global implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy-defibrillators (CRT-D) market is forecast to grow at a CAGR of 5% over the period 2010-2017 to reach revenue of USD 9.8 billion by 2017. Among the major drivers for this market growth one can name the increase in population of patients with cardiac arrhythmias and congestive heart failure (CHF) conditions and the continued adoption of ICDs and CRT-Ds for their treatment. The demand for continuously evolving technologies in ICDs and CRT-Ds will help sustain the market growth rate. By 2017, ICDs are expected to grow at a rate of 5% to reach USD 5.6 billion, while CRT-Ds are anticipated to grow at a 6% annual rate to gain revenue of USD 4.2 billion.

New research report “Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” developed by GlobalData has been recently published by Market Publishers Ltd.

Report Details:

Title: Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Published: November, 2011
Pages: 89
Price: US$ 3,500
http://marketpublishers.com/report/medicine_pharmaceuticals_biotechnology/healthcare_equipment_services/implantable_cardioverter_defibrillators_n_cardiac_resynchronization_therapy_defibrillators_global_pipeline_analysis_competitive_landscape_n.html

The research report provides key data, information and an all-encompassing analysis of the global implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators market.

Report Contents:

TABLE OF CONTENTS

1 TABLE OF CONTENTS

1.1 List of Tables
1.2 List of Figures

2 EXECUTIVE SUMMARY

2.1 The Global Implantable Cardioverter Defibrillators (ICD) and Cardiac Resynchronization Therapy-Defibrillators (CRT-D) Market is Forecast to Grow at a Rate of 5% Over the Period 2010–2017
2.2 Medtronic Dominates the Global ICD and CRT-D Market with a Share of More Than 40%
2.3 Increasing Patient Pool and Better Adoption Rates of ICD and CRT-D for Treatment of Cardiac Arrhythmias and Heart Failures to Drive Market Growth
2.4 The US is the Largest Market for ICD and CRT-D Devices Contributing about 56% of the Global Revenue in 2010

3 INTRODUCTION

3.1 GlobalData Report Guidance

4 DISEASE OVERVIEW - ARRHYTHMIA

4.1 Types of Arrhythmia
4.2 Symptoms

5 DEVICE OVERVIEW

5.1 Implantable Cardioverter Defibrillator (ICD)
5.1.1 Dual Chamber Implantable Cardioverter Defibrillator
5.1.2 Single Chamber Implantable Cardioverter Defibrillator
5.2 Cardio Resynchronization Therapy Defibrillators

6 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS AND CARDIAC RESYNCHRONIZATION THERAPY-DEFIBRILLATORS - MARKET CHARACTERIZATION

6.1 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators Market, Global, Revenue ($bn), Historic, 2003-2010
6.2 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators Market, Global, Revenue ($bn), Forecast, 2010-2017
6.3 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators, Key Technology Trends
6.3.1 Percutaneous Implantable ICDs
6.3.2 Subcutaneous ICDs
6.3.3 Automatic Diagnosis
6.4 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators, Market Dynamics
6.4.1 Market Drivers
6.4.2 Market Restraints

7 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS AND CARDIOVERTER RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY COUNTRY, REVENUE, 2003 - 2017

7.1 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the US, Revenue ($bn), Historic, 2003-2010
7.2 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the US, Revenue ($bn), Forecast, 2010-2017
7.3 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Canada, Revenue ($m), Historic, 2003 - 2010
7.4 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Canada, Revenue ($m), Forecast, 2010 - 2017
7.5 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the UK, Revenue ($m), Historic, 2003 - 2010
7.6 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the UK, Revenue ($m), Forecast, 2010 - 2017
7.7 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Germany, Revenue ($m), Historic, 2003 - 2010
7.8 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Germany, Revenue ($m), Forecast, 2010 - 2017
7.9 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, France, Revenue ($m), Historic, 2003 - 2010
7.10 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, France, Revenue ($m), Forecast, 2010 - 2017
7.11 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Italy, Revenue ($m), Historic, 2003 - 2010
7.12 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Italy, Revenue ($m), Forecast, 2010-2017
7.13 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Spain, Revenue ($m), Historic, 2003 - 2010
7.14 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Spain, Revenue ($m), Forecast, 2010 - 2017
7.15 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Japan, Revenue ($m), Historic, 2003 - 2010
7.16 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Japan, Revenue ($m), Forecast, 2010 - 2017
7.17 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, China, Revenue ($m), Historic, 2003 - 2010
7.18 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, China, Revenue ($m), Forecast, 2010-2017
7.19 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, India, Revenue ($m), Historic, 2003 - 2010
7.20 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, India, Revenue ($m), Forecast, 2010 - 2017
7.21 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Australia, Revenue ($m), Historic, 2003 - 2010
7.22 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Australia, Revenue ($m), Forecast, 2010 - 2017
7.23 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillator Market, Brazil, Revenue ($m), Historic, 2003 - 2010
7.24 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Brazil, Revenue ($m), Forecast, 2010 - 2017

8 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS AND CARDIAC RESYNCHRONIZATION THERAPY-DEFIBRILLATORS MARKET - STRATEGIC COMPETITIVE ASSESSMENT

8.1 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators, Global, Company Share (%), 2010
8.2 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators, Opportunities and Threats
8.2.1 Opportunities
8.2.2 Threats
8.3 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators, Key Market Participants
8.3.1 Medtronic, Inc
8.3.2 St Jude Medical, Inc
8.3.3 Boston Scientific Corporation
8.3.4 Biotronik
8.3.5 Sorin Group

9 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS AND CARDIAC RESYNCHRONIZATION THERAPY-DEFIBRILLATORS - KEY MARKETED PRODUCTS

9.1 Protecta XT DR/VR and Protecta DR/VR ICDs
9.1.1 Product Description
9.1.2 Features and Benefits
9.2 Secura DR/VR ICDs
9.2.1 Product Description
9.2.2 Features and Benefits
9.3 Protecta XT and Protecta CRT-Ds
9.3.1 Product Description
9.3.2 Features and Benefits
9.4 Consulta CRT-Ds
9.4.1 Product Description
9.4.2 Features and Benefits
9.5 Maximo II CRT-Ds
9.5.1 Product Description
9.6 AnalyST Accel ICDs
9.6.1 Product Description
9.6.2 Features and Benefits
9.7 Atlas and Atlas II ICDs
9.7.1 Product Description
9.7.2 Features and Benefits
9.8 Current Accel DR/VR ICDs
9.8.1 Product Description
9.8.2 Features and Benefits
9.9 Current RF ICDs
9.9.1 Product Description
9.9.2 Features and Benefits
9.10 Epic and Epic II ICDs
9.10.1 Product Description
9.10.2 Features and Benefits
9.11 Epic HF CRT-Ds
9.11.1 Product Description
9.11.2 Features and Benefits
9.12 Fortify and Fortify ST ICDs
9.12.1 Product Description
9.12.2 Features and Benefits
9.13 PROMOTE CRT-Ds
9.13.1 Product Description
9.13.2 Features and Benefits
9.14 TELIGEN ICDs
9.14.1 Product Description
9.14.2 Features and Benefits
9.15 CONFIENT ICDs
9.15.1 Product Description
9.15.2 Features and Benefits
9.16 VITALITY ICDs
9.16.1 Product Description
9.17 COGNIS CRT-Ds
9.17.1 Product Description
9.17.2 Features and Benefits
9.18 CONTAK RENEWAL Series CRT-Ds
9.18.1 Product Description
9.18.2 Features and Benefits
9.19 LIVIAN CRT-Ds
9.19.1 Product Description
9.19.2 Features and Benefits
9.20 Lumax 540 series ICDs and CRT-Ds
9.20.1 Product Description
9.20.2 Features and Benefits
9.21 Lumax 300/340 VR-T (XL)/DR-T ICD and CRT-Ds
9.21.1 Product Description
9.21.2 Features and Benefits
9.22 Ovatio CRT-D
9.22.1 Product Description
9.22.2 Features and Benefits
9.23 Paradym Family of ICDs
9.23.1 Product Description
9.23.2 Features and Benefits
9.24 Paradym CRT-D
9.24.1 Product Description
9.24.2 Features and Benefits

10 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS AND CARDIAC RESYNCHRONIZATION THERAPY-DEFIBRILLATORS - PIPELINE ASSESSMENT

10.1 Implantable Cardioverter Defibrillators, Pipeline Products
10.1.1 AnalyST ACCEL ICD
10.1.2 AnalyST ICD
10.1.3 CardiaLen ICD
10.1.4 Chronicle ICD
10.1.5 Current Plus ICD
10.1.6 ENERGEN ICD
10.1.7 FORTIFY ST ICD
10.1.8 INCEPTA ICD
10.1.9 Paradym DR ICD
10.1.10 Paradym VR Model 8250 ICD
10.1.11 PUNCTUA ICD
10.1.12 S-ICD
10.1.13 Unconditional MRI Compatible ICD
10.2 Cardiac Resynchronization Therapy-Defibrillators, Pipeline Products
10.2.1 ENERGEN CRT-D
10.2.2 INCEPTA CRT-D
10.2.3 Next Generation Quad Polar CRT- D
10.2.4 Paradym RF 8770 SonR CRT-D
10.2.5 Clinical Trials
10.2.6 Paradym RF CRT-D
10.2.7 Platinium ICD - CRT-D
10.2.8 Promote Quadra CRT- D
10.2.9 PUNCTUA CRT-D
10.2.10 Unify Quadra CRT-D

11 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS AND CARDIACRESYNCHRONIZATION THERAPY DEFIBRILLATOR MARKET - DEALS LANDSCAPE

11.1 Boston Scientific Corporation Completes Acquisition of Atritech
11.2 Boston Scientific Corporation Enters into an Agreement with Fukuda Denshi
11.3 St. Jude Medical Enters into an Agreement with iRhythm Technologies
11.4 CLT Forms Joint Venture Company with Erasmus
11.5 AorTech International Expands Licensing Agreement with St. Jude Medical

12 APPENDIX

12.1 Definitions
12.1.1 Cardiac Resynchronization Therapy - Defibrillator
12.1.2 Implantable Cardioverter Defibrillator
12.1.3 Dual Chamber Implantable Cardioverter Defibrillator
12.1.4 Single Chamber Implantable Cardioverter Defibrillator
12.2 Acronyms
12.3 Research Methodology
12.4 Secondary Research
12.5 Primary Research
12.6 Models
12.7 Forecasts
12.8 Expert Panels
12.9 GlobalData Consulting
12.10 Contact Us
12.11 Disclaimer
12.12 Sources

LIST OF TABLES

LIST OF FIGURES

COMPANIES MENTIONED

Medtronic, Inc
St Jude Medical, Inc
Boston Scientific Corporation
Biotronik
Sorin Group

More new market research reports by the publisher can be found at GlobalData page.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Tanya Rezler
Visit website